Aim No evidence‐based approach to the evaluation of CKD has been established. We sought
to identify clinical criteria to guide a rational diagnostic approach for the initial evaluation …

… a definitive clinical diagnosis. The goal of this study was to evaluate the utility of direct DNA
… who were judged to have polycystic kidney disease by standard clinical criteria. The samples …

The clinical utility of renal concentrating capacity in polycystic kidney disease. We studied
177 adult nonazotemic subjects with autosomal dominant polycystic kidney disease (ADPKD) …

… with CKD and to determine the clinical utility of genetic testing in these patients. To address
these issues, we designed an extensive kidney disease gene panel and performed genetic …

… and rare diseases, demonstrating the clinical applicability of … end points of the Renasight
Clinical Application, Review, and … -world diagnostic and clinical utility of broad panel genetic …

BTMs provide information that is complementary to other clinical tests. It may be envisioned
that in the near future, the assessment of nonkidney cleared BTMs may become part of …

… in the whole cohort and in specific disease aetiologies: diabetic nephropathy, hypertensive
… dominant polycystic kidney disease (ADPKD) and other diseases. Clinical utility was …

… of chronic kidney disease should be … The clinical utility of this guidance has not been
adequately evaluated in primary care, the setting in which most people with chronic kidney disease …

… To provide context for clinical utility of the KidneyIntelX test, the proportion of participants …
to the proportion as classified by their Kidney Disease Improving Global Outcomes (KDIGO) risk …

… In conclusion, our survey sheds light on the clinical utility of, advantages of, and perceived
barriers to using genetic tests among general nephrologists. These observations may support …